Sodium Tetradecyl Sulfate Coupons & Savings Card – Discount Prices from $350.56

Sodium tetradecyl sulfate (STS) is a medication used to treat small, uncomplicated varicose veins in the lower legs. While effective, it's important to be aware of certain risks associated with its use.

Allergic Reactions: Some individuals may experience severe allergic responses to STS, including life-threatening anaphylaxis. To minimize this risk, healthcare providers often administer a small test dose and monitor the patient closely before proceeding with a full treatment.

Blood Clots: There is a potential for blood clots to form in deeper veins (deep vein thrombosis) or to travel to the lungs (pulmonary embolism) following STS treatment. These events can occur up to four weeks after the procedure. Patients should be monitored during this period for any signs of clotting complications.

Arterial Embolism: Serious events such as stroke, transient ischemic attack, or heart attack have been reported in close temporal relationship with STS administration. These may be caused by air embolism when using the product foamed with room air or thromboembolism. The safety and efficacy of STS foamed with room air have not been established, and its use should be avoided.

Tissue Damage: If STS leaks out of the vein during injection (a situation known as extravasation), it can cause severe local tissue damage, including tissue death (necrosis). Proper injection technique is crucial to prevent this complication.

Occupational Exposure: Healthcare workers handling STS should use protective measures, as contact with the skin can lead to irritation or allergic reactions. Appropriate protective equipment, such as gloves, should be worn to minimize this risk.

Given these potential risks, STS should only be administered by healthcare professionals experienced in treating venous conditions and familiar with proper injection techniques. Patients should discuss their medical history and any concerns with their healthcare provider to ensure the safest possible treatment.

Sodium tetradecyl sulfate (STS) is a medication commonly used to treat small varicose veins in the legs. While generally effective, it's important to be aware of potential side effects associated with its use. Common Side Effects:

• Injection Site Reactions: Patients may experience pain, itching, redness, or swelling at the injection site. In some cases, ulceration or tissue damage can occur if the medication leaks into surrounding tissues.
• Skin Discoloration: A permanent darkening of the skin along the treated vein may develop.
• Headache and Nausea: Some individuals report mild headaches or feelings of nausea following treatment. Serious Side Effects:
• Allergic Reactions: Although rare, severe allergic responses such as hives, difficulty breathing, swelling of the face or throat, and anaphylactic shock have been reported. Immediate medical attention is required if these symptoms occur.
• Blood Clots: There is a risk of developing deep vein thrombosis (DVT) or pulmonary embolism (PE) after treatment. Symptoms may include pain, redness, or swelling in the limbs, chest pain, or shortness of breath.
• Neurological Events: In rare instances, patients have experienced visual disturbances, migraines, or even stroke-like symptoms following the procedure. Precautions: Before undergoing treatment with STS, inform your healthcare provider if you have a history of allergies, blood clotting disorders, asthma, or other significant health conditions. This medication is not recommended for individuals with certain medical issues, including acute infections, uncontrolled diabetes, or significant arterial disease. Always discuss the potential risks and benefits of STS treatment with your healthcare provider to determine if it's the right option for you.

When considering the use of sodium tetradecyl sulfate (STS) for treating varicose veins, it's important to be aware of potential interactions with other medications:

• Hormonal Contraceptives: There have been reports of serious adverse events, including fatalities, in patients who were taking hormonal contraceptives at the time of STS treatment. Therefore, it's crucial to inform your healthcare provider if you are using any form of hormonal birth control before undergoing sclerotherapy with STS.

• Heparin: STS should not be mixed in the same syringe with heparin, as they are incompatible.

Additionally, while no well-controlled studies have been conducted on patients taking antiovulatory agents, caution is advised. Your physician will need to evaluate the potential risks and benefits before proceeding with STS treatment if you are on such medications.

Always provide your healthcare provider with a complete list of all medications, supplements, and herbal products you are currently taking. This information is essential to assess any potential interactions and to ensure the safe and effective use of sodium tetradecyl sulfate in your treatment plan.